
Science Translational Medicine
- Volume 14
- Issue 667
- 19 Oct 2022

ONLINE COVER Tracking TAMs. This two-photon microscopy image shows uptake of perfluorocarbon-containing nanoparticles (PFC-NPs; red) by tumor-associated microglia and macrophages (TAMs) in a central nervous system (CNS) tumor. Vasculature is shown in yellow and tumor cells are shown in green. Increased TAM abundance in CNS tumors has been correlated to more aggressive disease; however, monitoring these cells in patients has only been achievable using invasive biopsies. Here, Croci et al. showed that CNS TAMs could be monitored by magnetic resonance imaging (MRI) for PFC-NPs enriched for the stable isotope, fluorine-19 (19F). The authors found that TAMs could be tracked longitudinally and in response to radiotherapy, highlighting the potential of 19F MRI as a monitoring strategy for patients with CNS tumors.
Credit: Davide Croci and Johanna Joyce, University of Lausanne, Switzerland- Weiwei Dai
- Fengting Wu
- et al.
Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir
- Jasmine Goh
- Sanjay De Mel
- et al.
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma
- Bo Zhou
- Jacqueline G. Lu
- et al.
Synaptogenic effect of APP-Swedish mutation in familial Alzheimer’s disease
- Candela Diaz-Canestro
- Brandon Pentz
- et al.
Lean body mass and the cardiovascular system constitute a female-specific relationship
Advertisement
Focus
Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine.
mission & scope